MICRO THERAPEUTICS INC
10QSB, EX-27.1, 2000-08-11
LABORATORY ANALYTICAL INSTRUMENTS
Previous: MICRO THERAPEUTICS INC, 10QSB, EX-10.1, 2000-08-11
Next: APCO ARGENTINA INC/NEW, 10-Q, 2000-08-11



<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM BALANCE
SHEET AND STATEMENT OF OPERATIONS IN FORM 10-QSB FOR THE SIX MONTHS ENDED JUNE
30, 2000 AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FORM 10-QSB.
</LEGEND>
<MULTIPLIER> 1,000

<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          DEC-31-2000
<PERIOD-START>                             JAN-01-2000
<PERIOD-END>                               JUN-30-2000
<CASH>                                          15,670
<SECURITIES>                                         0
<RECEIVABLES>                                    1,413
<ALLOWANCES>                                      (10)
<INVENTORY>                                      1,435
<CURRENT-ASSETS>                                19,064
<PP&E>                                           3,650
<DEPRECIATION>                                 (1,640)
<TOTAL-ASSETS>                                  22,685
<CURRENT-LIABILITIES>                            2,035
<BONDS>                                              0
                                0
                                          0
<COMMON>                                            10
<OTHER-SE>                                       9,039
<TOTAL-LIABILITY-AND-EQUITY>                    22,685
<SALES>                                          2,341
<TOTAL-REVENUES>                                 2,341
<CGS>                                            1,511
<TOTAL-COSTS>                                    5,937
<OTHER-EXPENSES>                                 (391)
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                 514
<INCOME-PRETAX>                                (5,230)
<INCOME-TAX>                                         1
<INCOME-CONTINUING>                            (5,231)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                   (5,231)
<EPS-BASIC>                                  $(0.56)
<EPS-DILUTED>                                  $(0.56)


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission